Update time. I had an appointment with my urologist yesterday. I received the lab test results several days earlier. T was 969 ng/dl, down from 1125 three months ago. Hematocrit was 50.9, down from 55.5 three months ago. In the meantime, I had voluntarily reduced my dosage from 40 mg every third day to 37.5 mg, or 375 mg/month from 400 mg three months ago.
My doc was perfectly happy with my T levels three months ago except the effect on hematocrit. That was the only driver of the dosage reduction, not the reference range used by LabCorp.
We discussed at some length the LabCorp decision to reduce its reference range. Doc said that there are 5 or 6 organizations that have an interest in T levels--the urologists, endocrinologists, etc., and that all of them use different reference ranges, regardless of the LabCorp recommendations. For his own practice, his approach is to prescribe an amount of T that will serve the physical and mental needs of his patients, regardless of reference ranges. He does not prescribe by the numbers. He did not seem concerned that the DEA might come looking around.
I asked about the pharmacy benefits manager issue that I started this conversation with. He didn't know what their reaction would be to a renewal of my Rx, but he is prepared to answer their questions if they are forthcoming. As for asking the pharmacy just to skip running it through my insurance, since they don't pay anything anyway, he said it depends whether the pharmacy has a contract with the PBM that requires them to submit all Rxs.
In the end, without any prompting from me, he renewed the Rx for another 5 months and we set a return visit for 3 months, so that he can continue to review the hematocrit and my PSA. I feel that I am in good hands with a flexible practitioner who doesn't feel bound my rigid limits.